Alira Health, a global healthcare advisory and technology company, and Bioga, non-profit business association that supports the value chain of the biotechnology sector with activities in Galicia , are pleased to announce the SME Market Access Support Program 2025.
The SME Market Access Support Program 2025 offers guidance from an experienced team of Market Access experts to help companies enhance their value proposition, navigate the price and reimbursement ecosystem in Europe, and define their market access needs and ambitions.
The program’s 40-hour package of service includes:
-
- background analysis
- maturity assessment
- market access roadmap creation
Three SMEs (medtech, pharma or biotech) will be selected for the program. The application is open to all SMEs in the IberoBio territory* that plan to pursue reimbursement/financing for their solution.
The interested SMEs will have the opportunity to learn all details about the SME Market Access Support Program 2025 during a presentation webinar:
-
- Date: 05/11/2024
- How to join: registration is required. Register here:
- Agenda:
-
- Bioga introduction
- Alira Health introduction
- Market access masterclass
- SME Market Access Support Program 2025 presentation
- Q&A on SME Market Access Support Program 2025
-
Registration for the program will be open on November 5th, following the presentational webinar.
“At Alira Health, we are committed to helping Iberian companies enter this highly competitive market. Market access strategy is a vital component in their success,” says Chus Castillo, Partner Consulting Iberia at Alira Health.
“At Bioga we work to support Galician biotech startups and small companies, and this programme in collaboration with Alira Health reinforces our position, especially in a key area such as access to the biotech and healthcare market,” says José Vilariño, President of Bioga.
